Jerome Benedict Durso insider trades

Open-market stock purchases and sales by Jerome Benedict Durso, President and CEO at Altimmune, Inc, from SEC Form 4 filings since Feb 23, 2017.

Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging -4%.

Recent trades

DateStockTradeValue
Aug 13, 2026ALT Altimmune, IncBought$44.3K
Apr 1, 2026ALT Altimmune, IncBought$47.1K
Mar 6, 2026ALT Altimmune, IncBought$70.8K
Dec 22, 2025ALT Altimmune, IncBought$51.6K
Dec 1, 2025ALT Altimmune, IncBought (not open market)—
Dec 1, 2025ALT Altimmune, IncBought (not open market)—

Companies traded

  • ALT Altimmune, Inc: 4 buys, last Aug 13, 2026
  • ICPT Intercept Pharmaceuticals, Inc: other filings, last Nov 8, 2023

Get free alerts when Jerome Benedict Durso files a new trade →